SAPIRSTEIN JAMES 4
4 · First Wave BioPharma, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
SAPIRSTEIN JAMES
DirectorPRESIDENT AND CEO
Transactions
- Award
Common Stock
2023-01-03+300,000→ 300,000 total
Footnotes (2)
- [F1]On January 3, 2023, the Reporting Person was granted 300,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning March 31, 2023.
- [F2]Includes unvested RSUs.